Key Takeaways The range is enormous: published elimination half-lives across peptide classes span from about 8 minutes (tesamorelin) to about a week (semaglutide) a factor of roughly 1,200 Half-life is not duration of effect: CJC-1295 has a reported half-life of 5.8-8.1 days but raised IGF-1 for 9-11 days after a single dose in the original trial Half-life is not a detection window: those are different measurements answering different questions, and we do not publish the second Molecular design drives everything: albumin binding, acylation, and conjugation are what separate a 10-minute peptide from a 7-day one Most research peptides have no human data: for compounds like BPC-157 the published pharmacokinetics are animal studies, not human trials "How long do peptides stay in your system?" has no single answer, because "peptides" is not a pharmacological category in any useful sense

2 / 13 Without enough B12, you might not have enough healthy red blood cells to move oxygen around your body (anemia)
Read our research peptide safety guide for a broader look at COAs, sterility, vendor transparency, and why injectable research compounds need extra caution
Patients with severe neurological complications from SARS-CoV-2 infection have an increased CSF Q-albumin ratio indicating BBB disruption, coupled with elevated CSF proteins, such as IL-8, which are associated with BBB disruption 65